Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALAI.L Regulatory News (ALAI)

  • There is currently no data for ALAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison reviews Aberdeen Latin American Income Fund

27 Feb 2020 17:38

RNS Number : 4140E
Aberdeen Latin American Inc Fd Ltd
27 February 2020
 

 

London, UK, 27 February 2020

Edison reviews Aberdeen Latin American Income Fund (ALAI)

Aberdeen Latin American Income Fund (ALAI) offers exposure to Latin American equities and government debt. It is managed by Aberdeen Standard Investments' (ASI's) global emerging markets equities and emerging market debt teams. While 2019 was a difficult year in terms of economic growth, the markets performed strongly, underlining the resilience of the region. The managers remain 'cautiously optimistic' on the outlook for Latin America, led by the largest economies Brazil and Mexico, which are supported by lower interest rates and stable inflation, while there is also a positive government reform agenda in Brazil. ALAI is continuing to deliver on its income objective without compromising on its capital growth potential. It has meaningful revenue reserves and the fund offers an attractive 5.1% yield.

 

ALAI's discount remains persistently wide, typically within a 10-16% range over the last three years. There is scope for an improved valuation if there is increased investor demand for exposure to Latin America. The current 12.5% discount to cum-income NAV compares to the 12.6% to 13.5% range of average discounts over the last one, three and five years. ALAI has paid a 3.5p per share annual dividend in each of the last four financial years and offers a 5.1% yield.

Click here to view the full report.

 

Subscribe to Edison's content to receive reports by email.

All reports published by Edison are free-to-access and available on the website.

 

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Mel Jenner, +44 (0)20 3077 5720

Sarah Godfrey, +44 (0)20 3681 2519

investmenttrusts@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group- 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAFLFVDFSIDFII
Date   Source Headline
2nd Nov 202112:36 pmRNSNet Asset Value(s)
1st Nov 20215:13 pmRNSGearing disclosure
29th Oct 202112:43 pmRNSNet Asset Value(s)
28th Oct 20211:13 pmRNSNet Asset Value(s)
27th Oct 202112:23 pmRNSNet Asset Value(s)
26th Oct 202111:26 amRNSNet Asset Value(s)
25th Oct 20213:03 pmRNSGearing Disclosure
25th Oct 202112:43 pmRNSNet Asset Value(s)
22nd Oct 20211:04 pmRNSNet Asset Value(s)
21st Oct 202112:05 pmRNSNet Asset Value(s)
20th Oct 20211:11 pmRNSNet Asset Value(s)
19th Oct 202112:29 pmRNSNet Asset Value(s)
18th Oct 202112:32 pmRNSGearing disclosure
18th Oct 202111:49 amRNSNet Asset Value(s)
15th Oct 202111:51 amRNSNet Asset Value(s)
14th Oct 202112:03 pmRNSPortfolio disclosure
14th Oct 202111:49 amRNSNet Asset Value(s)
13th Oct 202112:23 pmRNSNet Asset Value(s)
12th Oct 202112:44 pmRNSNet Asset Value(s)
11th Oct 202112:23 pmRNSGearing disclosure
11th Oct 202111:22 amRNSNet Asset Value(s)
8th Oct 20214:26 pmRNSHolding(s) in Company
8th Oct 202112:47 pmRNSNet Asset Value(s)
7th Oct 202112:29 pmRNSNet Asset Value(s)
6th Oct 20213:10 pmRNSMonth End Net Asset Value(s)
6th Oct 202111:04 amRNSNet Asset Value(s)
5th Oct 202111:30 amRNSNet Asset Value(s)
4th Oct 20213:03 pmRNSGearing disclosure
4th Oct 202112:31 pmRNSNet Asset Value(s)
4th Oct 20217:00 amRNSCompliance with Market Abuse Regulation
30th Sep 20211:59 pmRNSNet Asset Value(s)
30th Sep 20217:00 amRNSFourth Interim Dividend
29th Sep 202112:42 pmRNSNet Asset Value(s)
28th Sep 202112:30 pmRNSNet Asset Value(s)
27th Sep 20211:49 pmRNSGearing disclosure
27th Sep 202112:55 pmRNSNet Asset Value(s)
24th Sep 202111:53 amRNSNet Asset Value(s)
23rd Sep 202112:10 pmRNSNet Asset Value(s)
22nd Sep 202112:14 pmRNSNet Asset Value(s)
21st Sep 202111:54 amRNSNet Asset Value(s)
20th Sep 20213:15 pmRNSGearing disclosure
20th Sep 202112:49 pmRNSNet Asset Value(s)
17th Sep 202110:26 amRNSNet Asset Value(s)
16th Sep 202111:37 amRNSNet Asset Value(s)
15th Sep 202111:41 amRNSNet Asset Value(s)
14th Sep 202112:38 pmRNSPortfolio disclosure
14th Sep 202112:34 pmRNSNet Asset Value(s)
13th Sep 20213:06 pmRNSGearing disclosure
13th Sep 202111:32 amRNSNet Asset Value(s)
10th Sep 202111:54 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.